The molecular axis enclosing ERβ, matrix effectors (i.e., cell receptors and MMPs), and principal EMT mediators (i.e., E-cadherin and fibronectin), is critical for breast cancer progression and definitely affects response to endocrine therapy. The gene discussed is FN1; the disease is breast carcinoma.